期刊文献+

肥厚型脉络膜谱系疾病与脉络膜、涡静脉、巩膜改变的研究进展

Research progress on pachychoroid disease spectrum and changes in the choroid,vortex veins and sclera
下载PDF
导出
摘要 肥厚型脉络膜谱系疾病(pachychoroid disease spectrum,PCD)包括肥厚型脉络膜色素上皮病变(pachychoroid pigment epitheliopathy,PPE)、中心性浆液性脉络膜视网膜病变(central serous chorioretinopathy,CSC)、肥厚型脉络膜新生血管病变(pachychoroid neovasculopathy,PNV)、息肉样脉络膜血管病变(polypoidal choroidal vasculopathy,PCV)、局灶性脉络膜凹陷(focal choroidal excavation,FCE)和盘周肥厚型脉络膜综合征(peripapillary pachychoroid syndrome,PPS)。有学者将PCD看作脉络膜功能障碍引发的一系列连续疾病过程,但关于PCD的发病机制、形态改变尚未明确。该文对PCD的脉络膜、涡静脉及巩膜相关改变做一综述。 Pachychoroid disease spectrum include pachychoroid pigment epitheliopathy,central serous chorioretinopathy,pachychoroid neovasculopathy,polypoidal choroidal vasculopathy,focal choroidal excavation,and peripapillary pachychoroid syndrome.Currently,some scholars regard pachychoroid disease spectrum as a series of continuous disease processes caused by choroidal dysfunction,but the pathogenesis and morphological changes of pachychoroid disease spectrum are not yet clear.This paper reviews the changes of choroid,vortex veins and sclera in pachychoroid disease spectrum.
作者 熊晓媚 林振强(综述) 蔡晨希 王强 崔金利 林英(审校) XIONG Xiaomei;LIN Zhenqiang;CAI Chenxi;WANG Qiang;CUI Jini;LIN Ying(State Key Laboratory of Ophthalmology,Zhongshan Ophthalmic Center,Sun Yat-sen University,Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science,Guangzhou 510060,China)
出处 《眼科学报》 CAS 2023年第10期693-699,共7页 Eye Science
基金 白求恩·朗沐中青年眼科科研基金(BJ-LM2021014J) 广州市科技计划项目(SL2022A03J00452)。
关键词 肥厚型脉络膜谱系疾病 脉络膜 涡静脉 巩膜 综述 pachychoroid disease spectrum choroid vortex vein sclera review
  • 相关文献

参考文献4

二级参考文献40

  • 1Wang M, Munch IC, Hasler PW, Prunte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol 2008;86(2):126-145.
  • 2Liew G,?Quin G,?Gillies M,?Fraser-Bell S. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Experiment Ophthalmol 2013;41(2):201-214.
  • 3Gemenetzi M, Salvo GD, Lotery AJ. Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (Lond) 2010;24(12):1743-1756.
  • 4Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S; Central Serous Chorioretinopathy Case- Control Study Group.Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 2004;111(2):244-249.
  • 5Yannuzi LA, Gitter KA, Schatz H. Central serous chorioretinopathy In : Yannuzi LA, Gitter KA, Schatz H eds. The macula: a comprehensive text and atlas, Baltimore MD: Williams and Wilkins 1979:145-165.
  • 6Jain IS, Luthra CL, Das T. Beneficial effect of myopia on diabetic retinopathy. Indian J Ophthalmol 1965;13(3):88-94.
  • 7Lim LS, Lamoureux E, Saw SM, Tay WT, Mitchell P, Wong TY. Are myopic eyes less likely to have diabetic retinopathy? Ophthalmology 2010;117(3):524-530.
  • 8Tewari HK, Gadia R, Kumar D, Venkatesh P, Garg SP.Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study.Invest Ophthalmol Vis Sci 2006;47(8):3474-3478.
  • 9Yannuzzi LA. Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 2010;149(3):361-363.
  • 10Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996;16(3):203-213.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部